NEJM Group
NEJM Group is the nonprofit publishing division of the Massachusetts Medical Society, producing the New England Journal of Medicine and a portfolio of peer-reviewed digital journals serving clinicians, researchers, healthcare executives, and the Chinese medical community worldwide, monetized via subscriptions, institutional licensing, and AI content partnerships.
- Company typePrivate
- Founded1812
- HeadquartersWaltham, United States
- Headcount101–250
- GTM typeB2B and B2C
- OfferingServices
What NEJM Group does
NEJM Group is the publishing division of the Massachusetts Medical Society, a Massachusetts-incorporated nonprofit, headquartered in Waltham, MA. The organization publishes the New England Journal of Medicine, one of the oldest continuously published medical journals in the world (founded 1812), alongside a portfolio of specialized peer-reviewed digital journals: NEJM Clinician (weekly clinical intelligence), NEJM Evidence (clinical trial design and decision-making), NEJM AI (AI/ML in medicine), and NEJM Catalyst (healthcare delivery transformation). The portfolio also includes NEJM CareerCenter for physician recruitment and NEJM 医学前沿, a Chinese-language platform operated with Shanghai-based Jiahui Medical Research and Education.
The underlying technology consists of a digital publishing platform delivering peer-reviewed medical research and clinical content across multiple web properties (nejm.org, clinician.nejm.org, evidence.nejm.org, ai.nejm.org, catalyst.nejm.org), supported by rigorous editorial and peer-review standards that constitute the company's core technical and reputational differentiator. NEJM Group employs 101-250 staff and distributes content through both direct digital subscriptions via store.nejm.org and worldwide institutional licensing via Ovid Technologies, a Wolters Kluwer company. Recent strategic moves have expanded the model into B2B content licensing to AI platforms, including Abridge (clinical decision support) and Elsevier's LeapSpace (research-grade AI workspace), positioning NEJM's peer-reviewed corpus as reference data inside AI-powered clinical and research workflows.
Revenue mechanics rest on three streams: recurring individual subscriptions to NEJM-branded publications; recurring institutional licensing through Ovid/Wolters Kluwer for healthcare and academic institutions globally; and licensing/royalty arrangements with AI technology partners. The company serves practicing physicians and clinicians, medical researchers, healthcare executives and clinical leaders, and Chinese-language medical professionals. Pricing is not publicly disclosed. The organization is not venture-backed, not publicly traded, and operates under a nonprofit mission aligned with the Massachusetts Medical Society's advocacy for physicians and patients.
NEJM Group firmographics
Firmographics- Name
- NEJM Group
- Legal name
- Massachusetts Medical Society
- Website
- https://nejmgroup.org
- Company type
- Private
- Founded year
- 1812
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- NEJM Group is the nonprofit publishing division of the Massachusetts Medical Society, producing the New England Journal of Medicine and a portfolio of peer-reviewed digital journals serving clinicians, researchers, healthcare executives, and the Chinese medical community worldwide, monetized via subscriptions, institutional licensing, and AI content partnerships.
- Ownership category
- akta.pro rank
NEJM Group industry classification
Industry- Product category
- Medical Publishing
- NAICS
- Periodical Publishers (513120)
- SIC
- Periodicals: Publishing Or Publishing & Printing (2721)
- akta.pro primary industry
- Medical, Clinical & Biomedical Scholarly Publishing (EDAGAFAB)
- akta.pro secondary industries
- Academic & Scholarly Journals Publishing (Peer-Reviewed) (MPAJABAC), Interdisciplinary & Multidisciplinary Scholarly Publishing (EDAGAFAI)
Keywords
Where NEJM Group is headquartered
LocationHeadquarters
- HQ city
- Waltham
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NEJM Group business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Individual Subscriptions: Personal subscriptions to NEJM publications including NEJM, NEJM Clinician, NEJM Evidence, NEJM AI, and NEJM Catalyst available for individual clinicians and physicians.
- Institutional Licensing: Institutional access to NEJM Group publications distributed worldwide through Ovid Technologies, Inc. (a Wolters Kluwer company). Provides access to NEJM, NEJM Clinician, NEJM Evidence, NEJM AI, NEJM Catalyst, and the NEJM Archive to healthcare institutions and academic organizations.
- Content Licensing to Technology Partners: NEJM Group content is licensed to third-party platforms including Elsevier's LeapSpace AI workspace and Abridge's clinical decision support system, enabling AI-powered search and clinical documentation with peer-reviewed medical literature.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
NEJM Group product offering
Product offeringCore offering
NEJM Group publishes a portfolio of peer-reviewed medical journals and digital clinical publications led by the New England Journal of Medicine, the world's most cited medical journal. The company sells individual and institutional subscriptions, licenses peer-reviewed content to AI clinical platforms, and operates specialty digital journals covering clinical evidence, AI in medicine, healthcare delivery, physician career resources, and Chinese-language medical research.
Product overview
NEJM Group is a division of the Massachusetts Medical Society and the publisher of the New England Journal of Medicine, the most trusted and influential source of medical knowledge for over 200 years. The company's product portfolio includes The New England Journal of Medicine as the flagship peer-reviewed journal, alongside specialized digital publications: NEJM Clinician (a weekly digital publication for Internal Medicine clinicians), NEJM Evidence (a monthly digital journal on clinical trial design and decision-making), NEJM AI (a journal covering AI and machine learning in medicine), and NEJM Catalyst (targeting healthcare executives and clinical leaders). The portfolio also includes regional offerings such as NEJM 医学前沿 for the Chinese-language medical community and NEJM CareerCenter for physician employment resources. NEJM Group distributes content through institutional partners including Ovid Technologies for academic and healthcare institution access.
Differentiator
Problem solved
Functional benefit
Brands
- New England Journal of Medicine (NEJM): The most trusted, influential source of new medical knowledge and clinical best practices in the world, published for over 200 years
- NEJM Clinician
- NEJM Evidence
- NEJM AI
- NEJM Catalyst
- NEJM CareerCenter
- NEJM 医学前沿 (NEJM Chinese)
Products and services
- The New England Journal of Medicine (NEJM) The flagship peer-reviewed medical journal of NEJM Group, providing rigorously vetted and compiled medical research for physicians and patients for over 200 years. Features rigorously peer-reviewed research, topical reviews, interactive clinical content and cases.
- NEJM Clinician A weekly digital publication delivering expertly curated and actionable updates in a 30-minute read for Internal Medicine clinicians. Curates content from more than 150 peer-reviewed journals, featuring article types including Journal Watch, Guideline Watch, Drug Watch, and Clinical Conversations.
- NEJM Evidence A monthly digital journal presenting original research and bold ideas in clinical trial design and clinical decision-making, providing context and critical evaluation of methods and results. Features series such as Tomorrow's Trial, Patient Platform, and Stats, STAT!
- NEJM AI A peer-reviewed monthly journal dedicated to research and application of artificial intelligence and machine learning in medicine. Covers clinical AI developments, medical imaging AI, policy perspectives, and provides benchmark data sets and protocols. Also produces the NEJM AI Grand Rounds podcast.
- NEJM Catalyst A digital, peer-reviewed journal and event platform that brings together healthcare executives, clinical leaders, and clinicians to share innovative ideas and practical applications for enhancing value of healthcare delivery. Features a qualified Insights Council and live-streamed events.
- NEJM CareerCenter An employment resources platform for physicians providing automated job alerts, robust search functionality, planning guides, and tools to support professional development and career growth in healthcare.
- NEJM 医学前沿 (NEJM Chinese / Yi Xue Qian Yan)
Quantifiable outcome
- NEJM is the most cited medical journal in the world, demonstrating its unmatched influence in clinical practice and research
Companies that use NEJM Group
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles4 records
NEJM Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
NEJM Group partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and strategic.
- ElseviercoreNEJM Group content is licensed to Elsevier's LeapSpace research-grade AI workspace, which draws on 20+ million peer-reviewed articles and books from Elsevier and over 1,000 content licensing partners including NEJM Group. LeapSpace provides traceable citations and transparency features for institutional and academic users.
- AbridgecoreMulti-year content partnership integrating NEJM peer-reviewed clinical research into Abridge's AI-powered Clinical Decision Support system. The integration enables clinicians to access evidence-based research grounded in patient context during patient encounters through Abridge's ambient documentation workflow, combining real-time clinical evidence with AI-powered clinical notes.
- CIDRAP (Center for Infectious Disease Research and Policy)coreNEJM Evidence and CIDRAP launched Public Health Alerts, a new series for rapid communication of important public health data. The collaboration delivers information and early warnings about emerging health threats, enabling swift, informed responses across the U.S. and globally. The first alerts covered influenza virus characteristics and clade Ib mpox virus community transmission.
- Jiahui Medical Research and Education (JMRE)strategicJiahui Medical Research and Education (JMRE) of Shanghai collaborates with NEJM Group to produce NEJM 医学前沿, a Chinese-language digital platform that translates and delivers NEJM content to the Chinese medical community with local expert commentary from China-based physicians.
- Ovid Technologies/Wolters KluwercoreOvid Technologies, Inc. serves as the worldwide distributor for NEJM Group publications including the New England Journal of Medicine, NEJM Clinician, NEJM Evidence, NEJM AI, NEJM Catalyst, and the NEJM Archive, handling institutional sales and distribution globally.
Scale indicators3 records
Recent moves9 records
Expansion highlights5 records
NEJM Group competitors and assessment
Company assessmentBroad incumbents
- Wolters Kluwer: Global information services company that distributes NEJM Group content via Ovid and also publishes competing medical and clinical reference content (UpToDate, Lippincott). Both a critical channel partner and an overlapping peer in clinical knowledge publishing.
- Springer Nature: Large-scale academic publisher with Nature Medicine and extensive medical/scientific journal portfolio. Competes for high-impact research submissions and institutional library budgets alongside NEJM Group.
- Wiley: Major academic publisher with significant medical, nursing, and healthcare journal portfolio. Competes for institutional subscriptions and society journal publishing contracts in the medical space.
- Elsevier: Major academic and medical publisher (owner of The Lancet) and operator of the LeapSpace AI workspace that licenses NEJM content. Competes broadly across medical journal publishing while also being a content licensing partner.
Regional players
- Karger Publishers: Specialty medical and scientific publisher with strong European heritage, offering a portfolio of peer-reviewed clinical journals. Comparable peer in medical scholarly publishing though with greater specialty/regional concentration.
Emerging players
- Abridge: AI-powered clinical documentation and decision support company that has entered a multi-year content licensing partnership with NEJM Group. Represents an emerging clinical AI category where NEJM content is embedded, making it a strategic partner and adjacent player in clinical AI knowledge delivery.
Direct peers
- Annals of Internal Medicine (American College of Physicians): Top-tier peer-reviewed internal medicine journal from ACP. Direct competitor to NEJM for internal medicine research, with a similar clinician and academic target audience.
- The Lancet (Elsevier): Flagship general medical journal and specialty portfolio from Elsevier. Directly competes with NEJM as one of the top-tier peer-reviewed medical journals globally, targeting similar clinician and researcher audiences.
- BMJ (British Medical Association): Publisher of The BMJ and a portfolio of clinical specialty journals. Comparable peer offering peer-reviewed medical research with both subscription and open access models targeting practicing clinicians worldwide.
- JAMA Network (American Medical Association): Publisher of JAMA, JAMA Internal Medicine, and a portfolio of specialty peer-reviewed medical journals. Directly competes with NEJM Group for high-impact medical research submissions, clinician readership, and institutional subscriptions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
NEJM Group social profiles
Digital presenceNEJM Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
NEJM Group leadership team
Management profileNumber of profiles
Profiles8 records
NEJM Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NEJM Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NEJM Group
What does NEJM Group do?
NEJM Group publishes a portfolio of peer-reviewed medical journals and digital clinical publications led by the New England Journal of Medicine, the world's most cited medical journal. The company sells individual and institutional subscriptions, licenses peer-reviewed content to AI clinical platforms, and operates specialty digital journals covering clinical evidence, AI in medicine, healthcare delivery, physician career resources, and Chinese-language medical research.
Is NEJM Group a public or private company?
NEJM Group is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was NEJM Group founded?
NEJM Group was founded in 1812. It employs 101 to 250 people.
Where is NEJM Group based?
NEJM Group is headquartered in Waltham, United States, in the North America region.
How does NEJM Group make money?
Three revenue lines are on record. Individual Subscriptions are the primary driver. The others are institutional Licensing and content Licensing to Technology Partners.
Who are NEJM Group's main competitors?
Broad incumbents on record are Wolters Kluwer, Springer Nature, Wiley and Elsevier. Karger Publishers is listed as a regional player. Abridge is listed as an emerging player. Direct peers are Annals of Internal Medicine (American College of Physicians), The Lancet (Elsevier), BMJ (British Medical Association) and JAMA Network (American Medical Association).
Does NEJM Group have an API?
No public API is recorded for NEJM Group.
What industry is NEJM Group in?
NEJM Group's product category is Medical Publishing. Its primary akta.pro industry code is EDAGAFAB, Medical, Clinical & Biomedical Scholarly Publishing, with a secondary code of MPAJABAC, Academic & Scholarly Journals Publishing (Peer-Reviewed). Its NAICS code is 513120 and its SIC code is 2721.